QBLINTRO Trademark

Trademark Overview


On Wednesday, June 11, 2025, a trademark application was filed for QBLINTRO with the United States Patent and Trademark Office. The USPTO has given the QBLINTRO trademark a serial number of 99228718. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 17, 2026. This trademark is owned by Amgen Inc.. The QBLINTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of cancer and immune diseases and conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of lupus erythematosus, rheumatoid arthritis, multiple sclerosis, neuromyelitis optica and systemic sclerosis
qblintro

General Information


Serial Number99228718
Word MarkQBLINTRO
Filing DateWednesday, June 11, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations used for the treatment of cancer and immune diseases and conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of lupus erythematosus, rheumatoid arthritis, multiple sclerosis, neuromyelitis optica and systemic sclerosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Trademark Events


Event DateEvent Description
Wednesday, June 11, 2025NEW APPLICATION ENTERED
Wednesday, June 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 11, 2025APPLICATION FILING RECEIPT MAILED
Saturday, July 26, 2025ASSIGNED TO EXAMINER
Saturday, July 26, 2025NON-FINAL ACTION WRITTEN
Saturday, July 26, 2025NON-FINAL ACTION E-MAILED
Saturday, July 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 28, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 28, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, January 21, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 21, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 21, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 22, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED